Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henrik Orum

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Idrugs : the Investigational Drugs Journal|October 4, 2006
The application of locked nucleic acids in the treatment of cancerMiriam Frieden, Henrik Orum
Gastroenterology|April 17, 2012
MicroRNAs in liver diseaseXin Wei Wang, Niels H H Heegaard, Henrik Orum
Nucleic Acids Research|June 8, 2004
LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1Fabien Darfeuille, Jens Bo Hansen, Henrik Orum, et al.
Biochemistry|September 28, 2006
Aptamers targeted to an RNA hairpin show improved specificity compared to that of complementary oligonucleotidesFabien Darfeuille, Sandrine Reigadas, Jens Bo Hansen, et al.
Molecular Cancer Therapeutics|September 16, 2008
SPC3042: a proapoptotic survivin inhibitorJens Bo Hansen, Niels Fisker, Majken Westergaard, et al.
Nucleic Acid Therapeutics|August 20, 2013
Hepatotoxic potential of therapeutic oligonucleotides can be predicted from their sequence and modification patternPeter H Hagedorn, Victor Yakimov, Søren Ottosen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2009
MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunctionJannet Kocerha, Mohammad Ali Faghihi, Miguel A Lopez-Toledano, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Idrugs : the Investigational Drugs Journal|October 4, 2006
The application of locked nucleic acids in the treatment of cancerMiriam Frieden, Henrik Orum
Gastroenterology|April 17, 2012
MicroRNAs in liver diseaseXin Wei Wang, Niels H H Heegaard, Henrik Orum
Nucleic Acids Research|June 8, 2004
LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1Fabien Darfeuille, Jens Bo Hansen, Henrik Orum, et al.
Biochemistry|September 28, 2006
Aptamers targeted to an RNA hairpin show improved specificity compared to that of complementary oligonucleotidesFabien Darfeuille, Sandrine Reigadas, Jens Bo Hansen, et al.
Molecular Cancer Therapeutics|September 16, 2008
SPC3042: a proapoptotic survivin inhibitorJens Bo Hansen, Niels Fisker, Majken Westergaard, et al.
Nucleic Acid Therapeutics|August 20, 2013
Hepatotoxic potential of therapeutic oligonucleotides can be predicted from their sequence and modification patternPeter H Hagedorn, Victor Yakimov, Søren Ottosen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2009
MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunctionJannet Kocerha, Mohammad Ali Faghihi, Miguel A Lopez-Toledano, et al.
Pageof 1